Kansas Sci-Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Sci-Tech Reporter.

Press releases published on October 24, 2026

2 hours ago

TGC 2026: Tec-Do bringt „Navos Pro“ auf den Markt – für ergebnisorientierte KI am Arbeitsplatz

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: Tec-Do lanza Navos Pro, una solución de IA para el trabajo orientada a resultados

Indeterminate GlobeNewswire

2 hours ago

TGC 2026 : Tec-Do lance Navos Pro, une solution d’IA pour le travail axée sur les résultats

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: חברת Tec-Do השיקה את Navos Pro – פתרון בינה מלאכותית לעבודה, הממוקד בהשגת תוצאות

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: Tec-Do Meluncurkan Navos Pro, AI for Work yang Berorientasi pada Hasil

Indeterminate GlobeNewswire

2 hours ago

TGC 2026：テック・ドゥ、ビジネス成果を重視した業務向けAI、「ナヴォス・プロ」を発表

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: 테크두, 실질적 성과 창출에 초점 맞춘 업무용 AI 솔루션 ‘나보스 프로’ 출시

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: Tec-Do Melancarkan Navos Pro untuk AI for Work Berorientasikan Hasil

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: Tec-Do Lança Navos Pro, IA Voltada para Resultados no Trabalho

Indeterminate GlobeNewswire

2 hours ago

TGC 2026: Tec-Do เปิดตัว Navos Pro มุ่งพัฒนา AI เพื่อการทำงานที่มุ่งเน้นผลลัพธ์

Indeterminate GlobeNewswire

6 hours ago

2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember

Indeterminate GlobeNewswire

7 hours ago

JelluTide Gummies Introduces Jellu Tide Multi-Ingredient Dietary Supplement Formulation

Indeterminate GlobeNewswire

7 hours ago

Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress

Indeterminate GlobeNewswire

7 hours ago

Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors

Indeterminate GlobeNewswire

7 hours ago

DEEP Robotics Unveils Five Research Advances in Embodied AI

Indeterminate GlobeNewswire

7 hours ago

XBiotech gibt die Wahl von Sushma Shivaswamy und Jan-Paul Simard zu Co-Chief Executive Officers bekannt

Indeterminate GlobeNewswire

7 hours ago

XBiotech annonce la nomination de Sushma Shivaswamy et Jan-Paul Simard aux postes de co-directeurs généraux

Indeterminate GlobeNewswire

8 hours ago

NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma

Indeterminate GlobeNewswire

8 hours ago

NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…

Indeterminate GlobeNewswire

11 hours ago

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Indeterminate GlobeNewswire